90 related articles for article (PubMed ID: 23241250)
21. User reporting of medical device related incidents.
Sievänen H
Med Device Technol; 2003 May; 14(4):26-9. PubMed ID: 12774575
[TBL] [Abstract][Full Text] [Related]
22. Health technology assessment for medical devices in Europe. What must be considered.
Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
[TBL] [Abstract][Full Text] [Related]
23. [Medical device surveillance].
Meria P; Colchen A
Prog Urol; 1998 Dec; 8(6):1083-6. PubMed ID: 9894275
[TBL] [Abstract][Full Text] [Related]
24. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
25. Postmarketing evaluations help determine contraceptive safety, efficacy.
Netw Res Triangle Park N C; 1988; 9(2):1-2, 7. PubMed ID: 12280950
[TBL] [Abstract][Full Text] [Related]
26. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
[TBL] [Abstract][Full Text] [Related]
27. A policy framework for public health uses of electronic health data.
McGraw D; Rosati K; Evans B
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():18-22. PubMed ID: 22262589
[TBL] [Abstract][Full Text] [Related]
28. Potential role of postmarketing research.
Venulet J
Drugs Exp Clin Res; 1987; 13(11):673-83. PubMed ID: 3443043
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiological studies based on medical and administrative databases : a potential strength in France].
Goldberg M; Coeuret-Pellicer M; Ribet C; Zins M
Med Sci (Paris); 2012 Apr; 28(4):430-4. PubMed ID: 22549872
[TBL] [Abstract][Full Text] [Related]
30. Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis.
Kaltenthaler E; Boland A; Carroll C; Dickson R; Fitzgerald P; Papaioannou D
Health Technol Assess; 2011 May; 15(22):1-82, iii-iv. PubMed ID: 21561569
[TBL] [Abstract][Full Text] [Related]
31. Post-purchase reassessment and improvement of neuroendoscope holder: importance of physician-manufacturer communication.
Ogawa Y; Nakata Y; Tominaga T
Technol Health Care; 2014 Jan; 22(2):297-301. PubMed ID: 24576811
[TBL] [Abstract][Full Text] [Related]
32. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
33. Health technology assessment from a Canadian device industry perspective.
Ferrusi IL; Ames D; Lim ME; Goeree R
J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
[TBL] [Abstract][Full Text] [Related]
34. The changing environment for technological innovation in health care.
Goodman CS; Gelijns AC
Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
[TBL] [Abstract][Full Text] [Related]
35. [Medical devices vigilance].
Crickx B
Ann Dermatol Venereol; 2008 Jan; 135(1 Pt 2):1S70-2. PubMed ID: 18442667
[TBL] [Abstract][Full Text] [Related]
36. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
Reeve LM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):181-7. PubMed ID: 19589365
[TBL] [Abstract][Full Text] [Related]
37. [Barriers to clinical studies involving medical devices].
Wente MN
Z Evid Fortbild Qual Gesundhwes; 2012; 106(5):315-9; discussion 320-1. PubMed ID: 22818147
[TBL] [Abstract][Full Text] [Related]
38. [Proposal of guidelines for the set-up of pharmaco-epidemiologic studies in drug surveillance].
de Tricornot B; Saddier P; Bons B; Clément JP; Courtand M; Lamarque V; Thomas A; Tomczyk S; Vaissère J
Therapie; 1997; 52(6):579-85. PubMed ID: 9734111
[TBL] [Abstract][Full Text] [Related]
39. Medical device accident reporting: does it improve patient safety?
Nobel JJ
Stud Health Technol Inform; 1996; 28():29-35. PubMed ID: 10172828
[TBL] [Abstract][Full Text] [Related]
40. When should case-only designs be used for safety monitoring of medical products?
Maclure M; Fireman B; Nelson JC; Hua W; Shoaibi A; Paredes A; Madigan D
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():50-61. PubMed ID: 22262593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
